Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 1/2022

01-03-2022 | Metastasis | Original Research

Factors affecting the survival of patients with colorectal cancer using random survival forest

Authors: Ghodratollah Roshanaei, Malihe Safari, Javad Faradmal, Mohammad Abbasi, Salman Khazaei

Published in: Journal of Gastrointestinal Cancer | Issue 1/2022

Login to get access

Abstract

Purpose

Colorectal cancer is one of the most common cancers and the leading cause of cancer death in Iran. This study aimed to develop and validate a random survival forest (RSF) to identify important risk factors on mortality in colorectal patients based on their demographic and clinical-related variables.

Methods

In this retrospective cohort study, the information of 317 patients with colorectal cancer who were referred to Imam Khomeini Clinic of Hamadan during the years of 2002 to 2017 were examined. Patient survival was calculated from the time of diagnosis to death. In the present study, the RSF model was used to identify factors affecting patient survival. Also, the results of the RSF model were compared with the Cox model. The data were analyzed using R software (version 3.6.1) and survival packages.

Results

One-, 2-, 3-, 4-, 5-, and 10-year survival rates of included patients were 81.4%, 63%, 57%, 52%, 45%, and 34%, respectively, and the median survival was obtained to be 53 months. The number of 150 patients was died at this time period. The four most important predictors of survival included metastasis to other organs, WBC count, disease stage, and number of lymphomas involved. RSF method predicted survival better than the conventional Cox proportional hazard model.

Conclusion

We found that metastasis to other organs, WBC count, disease stage, and number of lymphomas involved were the most four most important predictors of low survival for colorectal cancer patients.
Literature
1.
go back to reference Wickham R, Lassere Y. The ABCs of colorectal cancer. Semin Oncol Nurs. 2007;23:1–8. Wickham R, Lassere Y. The ABCs of colorectal cancer. Semin Oncol Nurs. 2007;23:1–8.
2.
go back to reference Ju J-H, Chang S-C, Wang H-S, Yang S-H, Jiang J-K, Chen W-C, et al. Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Color Dis. 2007;22(8):855–62.CrossRef Ju J-H, Chang S-C, Wang H-S, Yang S-H, Jiang J-K, Chen W-C, et al. Changes in disease pattern and treatment outcome of colorectal cancer: a review of 5,474 cases in 20 years. Int J Color Dis. 2007;22(8):855–62.CrossRef
3.
go back to reference Toyoda Y, Nakayama T, Ito Y, Ioka A, Tsukuma H. Trends in colorectal cancer incidence by subsite in Osaka, Japan. Jpn J Clin Oncol. 2009;39(3):189–91.CrossRef Toyoda Y, Nakayama T, Ito Y, Ioka A, Tsukuma H. Trends in colorectal cancer incidence by subsite in Osaka, Japan. Jpn J Clin Oncol. 2009;39(3):189–91.CrossRef
4.
go back to reference Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89.PubMedPubMedCentral Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Prz Gastroenterol. 2019;14(2):89.PubMedPubMedCentral
5.
go back to reference Ministry of Health and Medical Education. Islamic Republic of Iran Ministry of Health and Medical Education, Office of Deputy Minister for Health Center for disease control, cancer office. Iranian Annual National Cancer Registration Report. 2006. Ministry of Health and Medical Education. Islamic Republic of Iran Ministry of Health and Medical Education, Office of Deputy Minister for Health Center for disease control, cancer office. Iranian Annual National Cancer Registration Report. 2006.
6.
go back to reference Chan J, Meyerhardt J, Niedzwiecki D. Family history of colorectal cancer: a new survival predictor of colon cancer? 2008. Chan J, Meyerhardt J, Niedzwiecki D. Family history of colorectal cancer: a new survival predictor of colon cancer? 2008.
7.
go back to reference Wilkes G, Hartshorn K. Colon, rectal, and anal cancers. Semin Oncol Nurs. 2009; Elsevier. Wilkes G, Hartshorn K. Colon, rectal, and anal cancers. Semin Oncol Nurs. 2009; Elsevier.
8.
go back to reference Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38(5):613–9.CrossRef Corrao G, Bagnardi V, Zambon A, La Vecchia C. A meta-analysis of alcohol consumption and the risk of 15 diseases. Prev Med. 2004;38(5):613–9.CrossRef
9.
go back to reference Kelsall HL, Baglietto L, Muller D, Haydon AM, English DR, Giles GG. The effect of socioeconomic status on survival from colorectal cancer in the Melbourne Collaborative Cohort Study. Soc Sci Med. 2009;68(2):290–7.CrossRef Kelsall HL, Baglietto L, Muller D, Haydon AM, English DR, Giles GG. The effect of socioeconomic status on survival from colorectal cancer in the Melbourne Collaborative Cohort Study. Soc Sci Med. 2009;68(2):290–7.CrossRef
10.
go back to reference Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Color Dis. 2008;23(7):683–8. Moghimi-Dehkordi B, Safaee A, Zali MR. Prognostic factors in 1,138 Iranian colorectal cancer patients. Int J Color Dis. 2008;23(7):683–8.
11.
go back to reference Young AM, Hobbs R, Kerr DJ. ABC of colorectal cancer: Wiley; 2011. Young AM, Hobbs R, Kerr DJ. ABC of colorectal cancer: Wiley; 2011.
12.
go back to reference Ramos M, Esteva M, Cabeza E, Campillo C, Llobera J, Aguiló A. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer. 2007;43(17):2467–78.CrossRef Ramos M, Esteva M, Cabeza E, Campillo C, Llobera J, Aguiló A. Relationship of diagnostic and therapeutic delay with survival in colorectal cancer: a review. Eur J Cancer. 2007;43(17):2467–78.CrossRef
13.
go back to reference Jayasekara H, English DR, Haydon A, Hodge AM, Lynch BM, Rosty C, et al. Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype. Int J Cancer. 2018;142(2):238–50.CrossRef Jayasekara H, English DR, Haydon A, Hodge AM, Lynch BM, Rosty C, et al. Associations of alcohol intake, smoking, physical activity and obesity with survival following colorectal cancer diagnosis by stage, anatomic site and tumor molecular subtype. Int J Cancer. 2018;142(2):238–50.CrossRef
14.
go back to reference Kleinbaum DG, Klein M. Survival Analysis. A self-learning text. Third ed. New York: Springer; 2012.CrossRef Kleinbaum DG, Klein M. Survival Analysis. A self-learning text. Third ed. New York: Springer; 2012.CrossRef
15.
go back to reference Radespiel-Tröger M, Rabenstein T, Schneider H, Lausen B. Comparison of tree-based methods for prognostic stratification of survival data. Artif Intell Med. 2003;28(3):323–41.CrossRef Radespiel-Tröger M, Rabenstein T, Schneider H, Lausen B. Comparison of tree-based methods for prognostic stratification of survival data. Artif Intell Med. 2003;28(3):323–41.CrossRef
16.
go back to reference Churpek MM, Yuen TC, Winslow C, Meltzer DO, Kattan MW, Edelson DP. Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards. Crit Care Med. 2016;44(2):368–74.CrossRef Churpek MM, Yuen TC, Winslow C, Meltzer DO, Kattan MW, Edelson DP. Multicenter comparison of machine learning methods and conventional regression for predicting clinical deterioration on the wards. Crit Care Med. 2016;44(2):368–74.CrossRef
17.
go back to reference Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2(3):841–60.CrossRef Ishwaran H, Kogalur UB, Blackstone EH, Lauer MS. Random survival forests. Ann Appl Stat. 2008;2(3):841–60.CrossRef
18.
go back to reference Yuan Y, Van Allen EM, Omberg L, Wagle N, Amin-Mansour A, Sokolov A, et al. Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol. 2014;32(7):644–52.CrossRef Yuan Y, Van Allen EM, Omberg L, Wagle N, Amin-Mansour A, Sokolov A, et al. Assessing the clinical utility of cancer genomic and proteomic data across tumor types. Nat Biotechnol. 2014;32(7):644–52.CrossRef
19.
go back to reference Sloan RA, Haaland BA, Sawada SS, Lee I-M, Sui X, Lee D-c, et al. A fit-fat index for predicting incident diabetes in apparently healthy men: a prospective cohort study. PLoS One. 2016;11(6):e0157703.CrossRef Sloan RA, Haaland BA, Sawada SS, Lee I-M, Sui X, Lee D-c, et al. A fit-fat index for predicting incident diabetes in apparently healthy men: a prospective cohort study. PLoS One. 2016;11(6):e0157703.CrossRef
20.
go back to reference Lawless JF, Yuan Y. Estimation of prediction error for survival models. Stat Med. 2010;29(2):262–74.PubMed Lawless JF, Yuan Y. Estimation of prediction error for survival models. Stat Med. 2010;29(2):262–74.PubMed
21.
go back to reference Gerds TA, Schumacher M. Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biom J. 2006;48(6):1029–40.CrossRef Gerds TA, Schumacher M. Consistent estimation of the expected Brier score in general survival models with right-censored event times. Biom J. 2006;48(6):1029–40.CrossRef
22.
go back to reference van der Geest LG, Koopman M, Verhoef C, Elferink MA, de Wilt JH. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015;32(5):457–65.CrossRef van der Geest LG, Koopman M, Verhoef C, Elferink MA, de Wilt JH. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases. Clin Exp Metastasis. 2015;32(5):457–65.CrossRef
23.
go back to reference Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6(1):1–9.CrossRef Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;6(1):1–9.CrossRef
24.
go back to reference Field K, Lipton L. Metastatic colorectal cancer-past, progress and future. World J Gastroenterol: WJG. 2007;13(28):3806–15.CrossRef Field K, Lipton L. Metastatic colorectal cancer-past, progress and future. World J Gastroenterol: WJG. 2007;13(28):3806–15.CrossRef
25.
go back to reference Gohari MR, Biglarian A, Bakhshi E, Pourhoseingholi MA. Use of an artificial neural network to determine prognostic factors in colorectal cancer patients. Asian Pac J Cancer Prev. 2011;12(6):1469–72.PubMed Gohari MR, Biglarian A, Bakhshi E, Pourhoseingholi MA. Use of an artificial neural network to determine prognostic factors in colorectal cancer patients. Asian Pac J Cancer Prev. 2011;12(6):1469–72.PubMed
26.
go back to reference Saki Malehi A, Hajizadeh E, Fatemi R. Evaluation of prognostic variables for classifying the survival in colorectal patients using the decision tree. Iran J Epidemiol. 2012;8(2):13–9. Saki Malehi A, Hajizadeh E, Fatemi R. Evaluation of prognostic variables for classifying the survival in colorectal patients using the decision tree. Iran J Epidemiol. 2012;8(2):13–9.
27.
go back to reference Prasanna T, Karapetis CS, Roder D, Tie J, Padbury R, Price T, et al. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern. Acta Oncol. 2018;57(11):1438–44.CrossRef Prasanna T, Karapetis CS, Roder D, Tie J, Padbury R, Price T, et al. The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern. Acta Oncol. 2018;57(11):1438–44.CrossRef
28.
go back to reference Moghimi DB, Safaei A, Zali M. Survival rates and prognostic factors in colorectal cancer patients. J Ilam Univ Med Sci. 2008;16(1):33–41. Moghimi DB, Safaei A, Zali M. Survival rates and prognostic factors in colorectal cancer patients. J Ilam Univ Med Sci. 2008;16(1):33–41.
29.
go back to reference Guthrie G, Roxburgh C, Farhan-Alanie O, Horgan P, McMillan D. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. Br J Cancer. 2013;109(1):24–8.CrossRef Guthrie G, Roxburgh C, Farhan-Alanie O, Horgan P, McMillan D. Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer. Br J Cancer. 2013;109(1):24–8.CrossRef
30.
go back to reference Zhang J, Zhang H-Y, Li J, Shao X-Y, Zhang C-X. The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(40):68837–46.CrossRef Zhang J, Zhang H-Y, Li J, Shao X-Y, Zhang C-X. The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis. Oncotarget. 2017;8(40):68837–46.CrossRef
31.
go back to reference Wu J, Ge XX, Zhu W, Zhi Q, Xu MD, Duan W, et al. Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer. Mol Med Rep. 2019;19(3):2330–40.PubMed Wu J, Ge XX, Zhu W, Zhi Q, Xu MD, Duan W, et al. Values of applying white blood cell counts in the prognostic evaluation of resectable colorectal cancer. Mol Med Rep. 2019;19(3):2330–40.PubMed
32.
go back to reference Li Q-Q, Lu Z-H, Yang L, Lu M, Zhang X-T, Li J, et al. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev. 2014;15(2):945–50.CrossRef Li Q-Q, Lu Z-H, Yang L, Lu M, Zhang X-T, Li J, et al. Neutrophil count and the inflammation-based glasgow prognostic score predict survival in patients with advanced gastric cancer receiving first-line chemotherapy. Asian Pac J Cancer Prev. 2014;15(2):945–50.CrossRef
33.
go back to reference Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil–lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–30.CrossRef Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil–lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–30.CrossRef
34.
go back to reference Xu Z, Berho ME, Becerra AZ, Aquina CT, Hensley BJ, Arsalanizadeh R, et al. Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy. J Clin Pathol. 2017;70(7):584–92.CrossRef Xu Z, Berho ME, Becerra AZ, Aquina CT, Hensley BJ, Arsalanizadeh R, et al. Lymph node yield is an independent predictor of survival in rectal cancer regardless of receipt of neoadjuvant therapy. J Clin Pathol. 2017;70(7):584–92.CrossRef
Metadata
Title
Factors affecting the survival of patients with colorectal cancer using random survival forest
Authors
Ghodratollah Roshanaei
Malihe Safari
Javad Faradmal
Mohammad Abbasi
Salman Khazaei
Publication date
01-03-2022
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 1/2022
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-020-00544-3

Other articles of this Issue 1/2022

Journal of Gastrointestinal Cancer 1/2022 Go to the issue